Copyright © 2013 American Medical Association. All rights reserved.

Slides:



Advertisements
Similar presentations
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Quality of Life After PCI vs CABG Among Patients.
Advertisements

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. Patterns and Predictors of Stress Testing Modality After.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 6/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Bacterial Coinfection in Influenza: A Grand Rounds.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Menopausal Hormone Therapy and Health Outcomes During.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Clopidogrel Pretreatment Before Percutaneous.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnoses and Timing of 30-Day Readmissions After.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Episodic Physical and Sexual Activity.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Smoking Is Associated With Adverse Clinical Outcomes.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Influenza Vaccination and Cardiovascular.
Date of download: 6/22/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Risk of End-Stage Renal Disease Following Live Kidney.
Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Drug-Eluting Versus Bare-Metal Stents During PCI.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Coronary Intervention Complications.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.
Date of download: 7/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Long-Term Outcomes of Older Diabetic Patients After.
Date of download: 7/5/2016 From: Validation of the Appropriate Use Criteria for Coronary Angiography: A Cohort Study Ann Intern Med. 2015;162(8):
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Prognostic Importance of Physical Examination for.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Fractional Flow Reserve Versus Angiography for Guiding.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reduced-Function CYP2C19 Genotype and Risk of Adverse.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Troponin Criteria for Myocardial Infarction After.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Date of download: 9/16/2016 Copyright © The American College of Cardiology. All rights reserved. From: 5-Year Clinical Outcomes of the ARTS II (Arterial.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
From: Contemporary Mortality Risk Prediction for Percutaneous Coronary Intervention: Results From 588,398 Procedures in the National Cardiovascular Data.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence and Correlates of Drug-Eluting Stent Thrombosis.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Endoscopic vs Open Vein-Graft.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Characteristics and Long-Term Outcomes of Percutaneous.
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Date of download: 9/20/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Palliative Care Intervention on Clinical.
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Efficacy and Safety of Dual Antiplatelet Therapy.
Copyright © 2014 American Medical Association. All rights reserved.
From: Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med.
Copyright © 2006 American Medical Association. All rights reserved.
From: Risks of Cardiovascular Adverse Events and Death in Patients with Previous Stroke Undergoing Emergency Noncardiac, Nonintracranial Surgery:The Importance.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2010 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Figure 3 One-year adverse events (death, post-discharge myocardial infarction, revascularization) after PCI according to patients who (A) would not have.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
From: Coronary Artery Plaque Burden and Perioperative Cardiac Risk
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
Glenn N. Levine et al. JACC 2016;68:
Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies  Hisato Takagi,
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction  P.-G. Chassot, A. Delabays, D.R. Spahn 
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.
Tornado diagram of one-way deterministic sensitivity analysis.
Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD 
Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?
For everything there is a season
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.
Current Clinical Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting  Michael J. Mack, MD, Syma L. Prince, RN, Morley Herbert,
Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era  Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
Glenn N. Levine et al. JACC 2011;58:e44-e122
Figures showing the effects of a potential 30% relative reduction in events with next-generation drug-eluting stents in the percutaneous coronary intervention.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization  Paul Kurlansky, MD, Morley Herbert, PhD, Syma.
Propensity score-matching
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Presentation transcript:

Copyright © 2013 American Medical Association. All rights reserved. From: Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents JAMA. 2013;310(14):1462-1472. doi:10.1001/jama.2013.278787 Figure Legend: Study Population With Exclusion CriteriaCABG indicates coronary artery bypass graft surgery; CMS, Centers for Medicare & Medicaid Services; FY, fiscal year; MI, myocardial infarction; VA, Veterans Affairs.aPatients may have had more than 1 percutaneous coronary intervention (PCI) care episode over the 10-year study period.bPatients may have had more than 1 surgical episode in the 24 months after a PCI episode. Date of download: 10/27/2017 Copyright © 2013 American Medical Association. All rights reserved.

Copyright © 2013 American Medical Association. All rights reserved. From: Risk of Major Adverse Cardiac Events Following Noncardiac Surgery in Patients With Coronary Stents JAMA. 2013;310(14):1462-1472. doi:10.1001/jama.2013.278787 Figure Legend: Unadjusted 30-Day Rate of Postoperative MACE After Noncardiac Surgery by Time Between Stent Date and Surgery DateLeft, plots created with R package GGPLOT2; smoothed trends were fitted using the loess algorithm. The lines represent the estimate of the rate and the shaded area around the line represents the 95% CI. Right, density plots of number of operations per day; y-axis intervals in blue indicate range from 0 to 50 operations/day. BMS indicates bare metal stent; DES, drug-eluting stent; MACE, major adverse cardiac event. Date of download: 10/27/2017 Copyright © 2013 American Medical Association. All rights reserved.

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.